ClinicalTrials.gg

Drug class

Dopamine Agents clinical trials

A class of medicines: the studies that test any of its 11 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.

studies test it
740
open now
58
in phase 3
181
first study started
1996

Keep track of what changes. Save the dopamine agents studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Medicines in this class

Studies that test each. A study of two counts under both, and once above.

Benserazide, levodopa drug combination
3

Studies by the year they started

735 studies that test it; most in 2009 (59); 3 more planned to start later

Studies that test Dopamine Agents, by start year
YearStudies
19963
19972
19981
19993
20004
200110
200213
200318
200431
200550
200648
200746
200838
200959
201034
201132
201230
201319
201427
201521
201624
201724
201825
201923
202023
202139
202220
202322
202423
202510
202613

By phase

A phase 1/2 study counts in both.

Early Phase 1
18
Phase 1
90
Phase 2
192
Phase 3
181
Phase 4
211
No phase
97

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 220 · Other 520

Eli Lilly and Company (91) · New York State Psychiatric Institute (15) · Massachusetts General Hospital (13) · Assiut University (12) · Knopp Biosciences (12) · Forest Laboratories (11) · Acorda Therapeutics (10) · University of Chicago (9)

Studies

Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.

Testing one of them · 740

See all 740 studies that test one of the dopamine agents →